A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India

A randomized, controlled, blinded, parallel group, clinical trial to study the role of Ayurcov (AyurCoro3), one day regimen as an adjuvant therapy for COVID-19 disease management, at dedicated Covid Hospital (DCH) in India

Introduction: Limited treatment options exist for COVID-19 infections; thus, attempts from complementary and alternative systems (CAM) of medicine are being explored as possible therapeutic options. Ayurcov is a formulation made of ingredients mentioned in Ayurveda. These constituents have proven an...

Full description

Bibliographic Details
Main Authors: Ajay Prabhakar Sankhe, Nanasaheb Somnath Memane, Vijaykumar P. Gawali, Sonal Nanasaheb Memane, Ganesh Ramakrishnan, Tapanendu Kundu, Mayur Nimba Bagul, Ashotosh Kumar, Vikram Bansal, Rashmi Tiwari
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Complementary Therapies in Medicine
Subjects:
COVID-19
Ayurveda
CAM
Complementary and alternative medicine
Ayurcov
Online Access:http://www.sciencedirect.com/science/article/pii/S0965229922000267

Internet

http://www.sciencedirect.com/science/article/pii/S0965229922000267

Similar Items